Clinical trials: Thrombophlebitis
Venous Insufficiency
Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings
Problem: Approximately 4 million live births occur in the United States each year. Pregnancy causes many physical changes in the mother, including venous distension, increased ability to form blood clots, and hormonal changes.
- Trial name
- NCT01793194
- Testing
- Compression Stockings
- Where
- United States
- Volunteers
- 44 people
- Sponsor
- Johns Hopkins University
Thrombosis, Venous
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
To evaluate fondaparinux 2.5mg subcutaneously once daily for 45 days in the treatment of acute (recent) superficial thrombophlebitis.
- Trial name
- NCT00443053
- Where
- 227 sites in Bulgaria, Czechia and 15 more
- Volunteers
- 3,002 people
- Sponsor
- GlaxoSmithKline
Intimate Partner Violence, Deep Vein Thrombosis (DVT)/Thrombophlebitis
Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations
Intimate violence against individuals, which is particularly marked among women, is one of the most widespread human rights violations in the world.
- Conditions
- Intimate Partner Violence, Deep Vein Thrombosis (DVT)/Thrombophlebitis, Pulmonary Embolism and Thrombosis
- Trial name
- HEMATO-WAST (NCT06415968)
- Where
- France
- Volunteers
- 138 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Superficial Vein Thrombosis, Endovenous Laser Ablation
Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
Рrospective single-centre randomized open-label study for comparison three modes of treatment for thrombosis of varicose great saphena vein - standard medical with fondaparinux sodium for 45 days, endovenous laser ablation close…
- Trial name
- NCT05001776
- Testing
- Endovenous laser ablation, Fondaparinux Sodium
- Where
- Russia
- Volunteers
- 105 people
- Sponsor
- National Medical Research Center for Therapy and Preventive Medicine
Superficial Thrombophlebitis, Upper Extremity Superficial Thrombophlebitis
Management of Superficial Thrombophlebitis
The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium) subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three times daily for 7 days for the treatment of superficial…
- Conditions
- Superficial Thrombophlebitis, Upper Extremity Superficial Thrombophlebitis, Lower Extremity Superficial Thrombophlebitis
- Trial name
- NCT00264381
- Testing
- Dalteparin sodium injection
- Where
- 2 sites in United States
- Volunteers
- 72 people
- Sponsor
- University of Oklahoma
Phlebitis, Thrombophlebitis
Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Patient Safety and Quality of Intravascular Access Devices Care Management - The Safe-IVADs Project. A Longitudinell Implementation Intervention With an Embedded Process Evaluation.
The goal of this observational study spanning over three years is to evaluate the effectiveness of implementing a co-designed, care bundle on intravascular access device (IVAD) quality and nurses and anaesthesiologist knowledge…
- Conditions
- Phlebitis, Thrombophlebitis, Infiltration of Peripheral IV Therapy, Extravasation Injury
- Trial name
- NCT07524608
- Testing
- The Safe IVADs project
- Where
- Sweden
- Volunteers
- 700 people
- Sponsor
- Sahlgrenska University Hospital
Embolism, Thrombophlebitis
Treatment for Blood Clots in the Veins of the Legs
Acute deep venous thrombosis (ADVT) of the lower extremity is a common disorder. Traditional treatment with anticoagulation therapy is effective in reducing the associated risk of pulmonary embolism, but is ineffective in…
- Trial name
- NCT00001713
- Testing
- Recombinant Tissue Plasminogen Activator, Heparin, Warfarin
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- National Institutes of Health Clinical Center (CC)
Superficial Thrombophlebitis
Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
The aim of the study is to establish whether treatment of superficial vein thrombosis (SVT) with low-molecular-weight heparin in preventive or therapeutic doses prevents disease progression and thromboembolic events (deep vein…
- Trial name
- REVETR (NCT01245998)
- Testing
- Dalteparin
- Where
- Slovenia
- Volunteers
- 68 people
- Sponsor
- University Medical Centre Ljubljana
Deep Vein Thrombosis
Diagnostic Performance of General Practitioners in Compression UltraSound
The objective of this study is to evaluate the diagnostic efficiency of general practitioners for the diagnosis of proximal deep vein thrombosis of the lower limbs compared with whole-leg ultrasound with Doppler performed by the…
- Trial name
- GPCUS (NCT05550038)
- Testing
- Compression ultrasound
- Where
- 19 sites in France
- Volunteers
- 15 people
- Sponsor
- University Hospital, Caen
Atrial Fibrillation
Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF
Atrial fibrillation (AF) remains a significant contributor to cardiovascular morbidity. Amiodarone is a potent antiarrhythmic drug; however, patients receiving IV amiodarone are at high risk for phlebitis.
- Trial name
- NCT01817439
- Testing
- Amiodarone
- Where
- Israel
- Volunteers
- 104 people
- Sponsor
- Western Galilee Hospital-Nahariya
COVID-19, Deep Vein Thrombosis (DVT)/Thrombophlebitis
COVID-19 and Deep Venous Thrombosis
The aim of this study is to investigate the prevalence and possible risk factors of the occurrence of a DVT in 12 intubated and mechanically ventilated COVID-19 patients admitted to the ICU at a single time point (29/03/2020).
- Trial name
- NCT04338932
- Where
- Belgium
- Volunteers
- 12 people
- Sponsor
- Jessa Hospital
Catheter Infection, Catheter Thrombosis
Midlines and Thrombophlebitis
Peripherally inserted central catheters (PICCs) are central catheters that are placed via peripheral vein under ultrasound guidance and may be used for patients with difficult venous access for long-term central or peripheral…
- Conditions
- Catheter Infection, Catheter Thrombosis, Catheter Complications
- Trial name
- NCT03725293
- Testing
- Angiodynamics BioFlo Midline Catheter, Teleflex Arrowg+ard Blue Advanced Midline Catheter
- Where
- United States
- Volunteers
- 212 people
- Sponsor
- Corewell Health East
Thrombosis
Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis
Background: Contrast-enhanced ultrasound (CEUS) visualization of the adventitial vasa vasorum. Late phase CEUS detect inflammation by visualizing microbubbles phagocytosed by monocytes.
- Trial name
- NCT01367769
- Testing
- No intervention
- Where
- Switzerland
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Thrombophlebitis Leg
Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance
Oral enzyme therapy in patients with acute superficial vein inflammation (thrombophlebitis) can serve as an additional treatment option besides standard therapy with compression stockings, common pain medication and physical…
- Trial name
- NCT03470337
- Testing
- Phlogenzym
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- Mucos Pharma GmbH & Co. KG
Varicose Veins
Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins
The overall objective will be to evaluate clinical predictors of outcomes in patients who undergo endovenous sclerotherapy for the treatment of varicose veins.
- Trial name
- NCT00954980
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University of Oklahoma
Deep Vein Thrombosis, Superficial Thrombophlebitis
DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
Study using a decision algorithm for the application of an oral anticoagulant calculator in vascular diseases, aimed at validating a clinical decision-support tool for conditions such as deep vein thrombosis, superficial…
- Conditions
- Deep Vein Thrombosis, Superficial Thrombophlebitis, Pulmonary Thromboembolisms, Clinical Decision Support Systems
- Trial name
- DOACT (NCT07290608)
- Testing
- DOACT algorithm, No algorithm, LLM-based tools
- Where
- Brazil
- Volunteers
- 59 people, healthy volunteers welcome
- Sponsor
- ITALO EUGENIO SOUZA GADELHA DE ABREU
Thrombophlebitis
Comparison of Dwell Time of Open Versus Closed Type Peripheral Intravenous Cannula
Studies have shown that stabilisation devices are associated with fewer complications and lower failure rates in peripheral catheters.3,6,7 Although closed-system peripheral catheters offer potential advantages, such as reduced…
- Trial name
- COT-cannula (NCT07182877)
- Testing
- Closed-type peripheral cannula, Open type peripheral cannula
- Where
- India
- Volunteers
- 100 people
- Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
Phlebitis, Thrombophlebitis
The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults
The goal of this randomised controlled trial is to determine the effectiveness of topical sesame oil in preventing phlebitis at peripheral intravenous (IV) cannula sites in adult patients within a cardiovascular and…
- Trial name
- NCT06216522
- Testing
- Topical Sesame Oil, Liquid paraffin oil
- Where
- Singapore
- Volunteers
- 263 people, healthy volunteers welcome
- Sponsor
- National Heart Centre Singapore
Arrhythmia, Atrial Fibrillation
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
To determine the benefits and risks of oral anticoagulant therapy in reducing embolic stroke and systemic emboli in patients with atrial fibrillation without rheumatic heart disease.
- Conditions
- Arrhythmia, Atrial Fibrillation, Cardiovascular Diseases, Cerebral Embolism and Thrombosis
- Trial name
- NCT00000517
- Testing
- warfarin
- Sponsor
- Massachusetts General Hospital
Thrombophlebitis
Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis
The optimal treatment of superficial venous thrombosis (SVT) is still uncertain. Though low molecular weight heparin (LMWH) is considered the treatment of choice, studies conducted so far do not give clear indications of the…
- Trial name
- NCT00362947
- Testing
- LMWH parnaparin subcutaneously
- Where
- 2 sites in Italy
- Volunteers
- 664 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna